Overview
Financials
Revenue history
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 2 of 5 financial statements were filed late (the longest delay 121 days for 2022), 1 not filed.
- 2023not filed
- 202213/11/2023
- 202128/10/2022
- 202027/09/2021
- 201915/10/2020
- 2018not filed
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Bogna Drewsage 48 | 24 | $324.15 | 24% |
Mariusz Piotr Kłobuckiage 47 | 24 | $324.15 | 24% |
| 52 | $702.32 | 52% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
1 closed proceeding recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Oct 12, 2022 | Discontinued enforcement proceedings | Closed |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
Last updated: 2026-04-10